Source:http://linkedlifedata.com/resource/pubmed/id/19242369
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003316,
umls-concept:C0006826,
umls-concept:C0014644,
umls-concept:C0021083,
umls-concept:C0035647,
umls-concept:C0039194,
umls-concept:C0085358,
umls-concept:C0086418,
umls-concept:C0175727,
umls-concept:C0205369,
umls-concept:C0871261,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1704632,
umls-concept:C1706438,
umls-concept:C1706817,
umls-concept:C1879547,
umls-concept:C2698600,
umls-concept:C2911692
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-4-30
|
pubmed:abstractText |
The efficacy of current cancer vaccines is limited by the functional heterogeneity and poor availability and expansion of professional antigen-presenting cells (APCs). Besides their potent innate effector properties, gammadelta T cells have been suggested to be involved in the initiation and maintenance of adaptive immune responses. Here, we investigated the capacity of human gammadelta T cells to induce expansion of virus-specific T cells to Epstein Barr virus (EBV) antigens. Aminobisphosphonate-stimulated human peripheral blood-derived gammadelta T cells (Vgamma2+Vdelta2+) acquired a dual phenotype characteristic for both APCs and effector memory T cells. Coincubation of activated gammadelta T cells pulsed with human leukocyte antigen-restricted epitopes of either the highly stimulatory EBV lytic cycle antigen Bam H1 Z fragment leftward open reading frame or the tumor-associated latent EBV antigen latent membrane protein 2a (LMP2a) with autologous peripheral blood lymphocytes induced selective expansion of peptide-specific, fully functional CD3CD8 cytolytic effector memory T cells. Furthermore, gammadelta T APCs efficiently processed and presented endogenous antigen, as demonstrated by the capacity of LMP2a gene-transduced gammadelta T cells to induce expansion of T cells with broad specificity for various LMP2a peptides. The capacity of autologous gammadelta T cells to induce LMP2a-specific autologous cytotoxic T lymphocytes was confirmed in 2 patients with Hodgkin lymphoma. In summary, bisphosphonate-activated human gammadelta T cells stimulate expansion of cytotoxic effector T cells specific for both subdominant and dominant viral epitopes and thus show promise as a novel source of efficient APCs for immunotherapy of viral and malignant disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1537-4513
|
pubmed:author |
pubmed-author:AltvaterBiancaB,
pubmed-author:BispingGuidoG,
pubmed-author:BollardCatherine MCM,
pubmed-author:HansmeierAnnaA,
pubmed-author:JuergensHeribertH,
pubmed-author:LandmeierSilkeS,
pubmed-author:MoosmannAndreasA,
pubmed-author:PschererSibylleS,
pubmed-author:RossigClaudiaC,
pubmed-author:VarnholtLenaL
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
310-21
|
pubmed:dateRevised |
2011-9-22
|
pubmed:meshHeading |
pubmed-meshheading:19242369-Antigen-Presenting Cells,
pubmed-meshheading:19242369-Antigens, Viral,
pubmed-meshheading:19242369-CD8-Positive T-Lymphocytes,
pubmed-meshheading:19242369-Cell Line, Tumor,
pubmed-meshheading:19242369-Diphosphonates,
pubmed-meshheading:19242369-Epitopes,
pubmed-meshheading:19242369-Epstein-Barr Virus Infections,
pubmed-meshheading:19242369-Herpesvirus 4, Human,
pubmed-meshheading:19242369-Humans,
pubmed-meshheading:19242369-Imidazoles,
pubmed-meshheading:19242369-Immunotherapy,
pubmed-meshheading:19242369-Receptors, Antigen, T-Cell, gamma-delta,
pubmed-meshheading:19242369-Transduction, Genetic,
pubmed-meshheading:19242369-Tumor Necrosis Factor-alpha
|
pubmed:year |
2009
|
pubmed:articleTitle |
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
|
pubmed:affiliation |
Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Street 33, Munster D-48149, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|